We report gene transfer to the normal and injured murine pulmonary circulat
ion via systemic (intravascular) and airway (intratracheal) delivery of nov
el polycationic liposomes (imidazolium chloride, imidazolinium chloride-cho
lesterol, and ethyl phosphocholine). With use of the reporter genes chloram
phenicol acetyltransferase (CAT) or human placental alkaline phosphatase (h
pAP), intravascular injection of lipid-DNA complexes resulted in gene expre
ssion primarily in the lung, with lesser expression in the heart (11% of lu
ng, P < 0.05) and spleen (8% of lung, P < 0.05). Histochemical staining for
the hpAP reporter gene showed localized transgene expression in the microv
ascular endothelium. Monocrotaline (80 mg/kg body wt sc) treatment produced
endovascular inflammation and reduced lung CAT activity (2 days postintrav
ascular transfection) by 75 +/- 8 and 86 +/- 6% at 7 and 21 days, respectiv
ely, after monocrotaline (P < 0.05). Despite the apparent decrease in funct
ional CAT protein, Southern blot analysis suggested maintained plasmid deli
very whereas quantitative PCR (TaqMan) showed decreased CAT mRNA levels in
monocrotaline mice. in contrast, intratracheal delivery of lipid-DNA comple
xes showed enhanced CAT expression in monocrotaline mice. Transfection in a
lternate pulmonary vascular disorders was studied by inducing hypoxic pulmo
nary hypertension (4 wk at barometric pressure of 410 mmHg). Efficiency and
duration of gene transfer, assessed by CAT activity, were similar in pulmo
nary hypertensive and normal lungs. We conclude that imidazolinium-derived
polycationic liposomes provide a means of relatively selective and efficien
t gene transfer to the normal and injured murine microvascular circulation,
although translation of transgene mRNA may be reduced by preexisting endot
helial injury.